$DUKR 4 SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Maor Vadim, CHIEF TECHNOLOGY OFFICER Granted 28,000 Option to Purchase Common Stock
06 Oct 2026	Form 4: Nachtomy Erez, Director Granted 28,000 Option to Purchase Common Stock
06 Oct 2026	Form 4: Kleinman Yiftach, CHIEF EXECUTIVE OFFICER Granted 53,600 Option to Purchase Common Stock
06 Oct 2026	Form 4: Levin Avi, CHIEF FINANCIAL OFFICER Granted 35,000 Option to Purchase Common Stock
02 Jul 2026	Form 4: Balucka Yossef, CHIEF EXECUTIVE OFFICER Received 18,000 shares by exercise or conversion ($1.8)
17 Mar 2026	Form 4: Antebi Eran, Director Granted 4,000 Option to Purchase Common Stock
12 Mar 2026	Form 4: Zakai Shlomo, CHIEF FINANCIAL OFFICER Granted 10,000 Option to Purchase Common Stock
12 Mar 2026	Form 4: Golan Keren Gousman, Director Granted 4,000 Option to Purchase Common Stock
12 Mar 2026	Form 4: Maor Vadim, CHIEF TECHNOLOGY OFFICER Granted 4,000 Option to Purchase Common Stock
12 Mar 2026	Form 4: Balucka Yossef, CHIEF EXECUTIVE OFFICER Granted 16,000 Option to Purchase Common Stock
12 Mar 2026	Form 4: Nachtomy Erez, Director Granted 16,000 Option to Purchase Common Stock
20 Mar 2025	Form 4: Zakai Shlomo, CHIEF FINANCIAL OFFICER Granted 50,000 Option to Purchase Common Stock
20 Mar 2025	Form 4: Balucka Yossef, CHIEF EXECUTIVE OFFICER Granted 1,000,000 Option to Purchase Common Stock
20 Mar 2025	Form 4: Maor Vadim, Chief Technology Officer Granted 500,000 Option to Purchase Common Stock
15 Jul 2022	Form 4: Aharon Sagiv, Director Disposed of 157,094 shares (Other Transaction)
15 Jul 2021	Form 4: Antebi Eran, Director Granted 120,000 Stock Option (right to buy)
15 Jul 2021	Form 4: Aharon Sagiv, Director Granted 120,000 Stock Option (right to buy)
15 Jul 2021	Form 4: Nachtomy Erez, Director Granted 200,000 Stock Option (right to buy)
15 Jul 2021	Form 4: Zakai Shlomo, Chief Financial Officer Granted 50,000 Stock Option (right to buy)
31 Mar 2021	Form 4: Balucka Yossef, CEO and President Granted 450,000 Stock Option (right to buy)

Comments